Trump announces full tariff on drugs to encourage pharmaceutical agreements.
In an era where healthcare costs continue to rise, President Trump’s recent executive order to impose potential tariffs on imported pharmaceuticals is both a contentious and strategic move aimed at reshaping the American healthcare landscape. While the implications of such tariffs remain to be fully realized, the administration’s approach reflects a growing urgency to secure…
